InterMune has also granted the underwriters a 30-day option to purchase up to an additional 525,000 shares of common stock. All of the shares in the offering are being sold by InterMune.
Goldman, Sachs & Company is acting as the sole book-running manager of the offering. Deutsche Bank Securities is acting as co-lead manager and CIBC World Markets is acting as co-manager of the offering.